Free Trial

Alpha Teknova Q3 2024 Earnings Report

Alpha Teknova logo
$5.19 0.00 (0.00%)
As of 04:00 PM Eastern

Alpha Teknova EPS Results

Actual EPS
-$0.15
Consensus EPS
-$0.11
Beat/Miss
Missed by -$0.04
One Year Ago EPS
-$0.34

Alpha Teknova Revenue Results

Actual Revenue
$9.58 million
Expected Revenue
$9.30 million
Beat/Miss
Beat by +$280.00 thousand
YoY Revenue Growth
N/A

Alpha Teknova Announcement Details

Quarter
Q3 2024
Time
After Market Closes
Remove Ads

Alpha Teknova Earnings Headlines

A market crash is coming—here’s when
The stock market cycle I've used to identify the most likely day of the next market crash is the exact same indicator that helped me call the bear market of 2018... the bull market in 2020... the bear market in 2022... the roaring bull markets in 2023 and 2024... and more. I'm convinced it has helped me identify the next big crash too. We are at an important juncture in the markets. Knowing what to do in the months to come is critical.
See More Alpha Teknova Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Alpha Teknova? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alpha Teknova and other key companies, straight to your email.

About Alpha Teknova

Alpha Teknova (NASDAQ:TKNO) produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

View Alpha Teknova Profile

More Earnings Resources from MarketBeat